N-of-1 Randomized Clinical Trials in Pharmacoepidemiology

Pharmacoepidemiology, Fourth Edition

Volumn , Issue , 2007, Pages 665-680

  Guyatt, Gordon H ^a,b   Jaeschke, Roman ^a,b,c   Roberts, Robin ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

^c Polish Institute for EBM   (Poland)

Author keywords

"pure" quantitative randomization test; Assessing potential drug impact; Interpreting data parametric tests; Measurement of outcome; N of 1 RCTs; Open run in period role; Randomized clinical trials in pharmacoepidemiology; Randomized controlled trials (RCTs); Time honored "trial of therapy"

Indexed keywords

EID: 84889468686     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059876.ch43     Document Type: Chapter

References (46)

1. Guyatt G, Cook D, Devereaux PJ, Meade M, Straus S. Therapy. In: Guyatt G, Rennie D, eds, The Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago, IL: AMA, 2002.
2. Dans A, McAlister F, Dans L, Richardson WS, Straus S, Guyatt G. Applying results to individual patients. In: Guyatt G, Rennie D, eds, The Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Chicago, IL: AMA, 2002.
3. Guyatt GH, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S. Determining optimal therapy: randomized trials in individual patients. N Engl J Med 1986; 314: 889-92.
4. Kratchwill TR. Single Subject Research: Strategies for Evaluating Change. Orlando, FL: Academic Press, 1978.
5. Kazdin AE. Single-Case Research Designs: Methods for Clinical and Applied Settings. New York: Oxford University Press, 1982.
6. Guyatt GH, Sackett DL, Adachi JD, Roberts RS, Chong J, Rosenbloom D et al. A clinician's guide for conducting randomized trials in individual patients. Can Med Assoc J 1988; 139: 497-503.
7. Guyatt GH, Keller JL, Jaeschke R, Rosenbloom R, Adachi JD, Newhouse MT. Clinical usefulness of the N of 1 randomized control trials: three year experience. Ann Intern Med 1990; 112: 293-9.
8. Jaeschke R, Adachi JD, Guyatt GH, Keller JL, Wong B. Clinical usefulness of amitryptiline in fibromyalgia: the results of 23 randomized controlled trials. J Rheumatol 1991; 18: 226S-33S.
9. Patel A, Jaeschke R, Guyatt G, Newhouse MT, Keller J. Clinical usefulness of N-of-1 RCTs in patients with chronic airflow limitation. Am Rev Respir Dis 1991; 144: 962-4.
10. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769-76.
11. Jaeschke R, Singer J, Guyatt GH. A comparison of 7 point and visual analogue scales: data from a randomized trial. Control Clin Trials 1990; 11: 43-51.
12. DeProspero A, Cohen S. Inconsistent visual analysis of intrasubject data. J Appl Behav Anal 1979; 12: 573-9.
13. Beyer WH, ed., CRC Handbook of Tables for Probability and Statistics, 2nd edn. Cleveland, OH: Chemical Research Co., 1968.
14. Conover WJ. Practical Nonparametric Statistics. New York: John Wiley & Sons, 1971; pp. 206-15.
15. Edgington ES. Randomization Tests, 2nd edn. New York: Marcel Dekker, 1987.
16. Huitema BE. Autocorrelation in applied behavior analysis: a myth. Behav Assess 1985; 7: 107-18.
17. Gastwirth JL, Bubin H. Effect of dependence on level of significance of a one sample test. J Am Stat Assoc 1971; 66: 816-20.
18. Rochon J. A statistical model for the "N-of-1" study. J Clin Epidemiol 1990; 43: 499-508.
19. Jaeschke R, Guyatt GH, Keller J, Singer J. Interpreting changes in quality-of-life score in N of 1 randomized trials. Control Clin Trials 1991; 12 (suppl): 226S-33S.
20. Jaeschke R, Guyatt G, Keller J, Singer J. Measurement of health status: ascertaining the meaning of a change in quality-of-life questionnaire score. Control Clin Trials 1989; 10: 407-15.
21. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality-of-life questionnaire. J Clin Epidemiol 1994; 47: 81-7.
22. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality-of-life questionnaire data. J Allergy Clin Immunol 1996; 98: 843-5.
23. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality-of-life in children with asthma. Qual Life Res 1996; 5: 35-46.
24. Keller JL, Guyatt GH, Roberts RS, Adachi JD, Rosenbloom D. An N-of-1 service: applying the scientific method in clinical practice. Scand J Gastroenterol 1988; 23: 22-9.
25. Larson EB. N-of-1 clinical trials. A technique for improving medical therapeutics. West J Med 1990; 152: 52-6.
26. Larson EB, Ellsworth AJ, Oas J. Randomized clinical trials in single patients during a two-year period. JAMA 1993; 270: 2708-12.
27. Guyatt GH, Heyting A, Jaeschke R, Keller J, Adachi JD, Roberts RS. N-of-1 trials for investigating new drugs. Control Clin Trials 1990; 11: 88-100.
28. Haines DR, Gaines SP. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. Pain 1999; 83: 283-7.
29. Chatellier G, Day M, Bobrie G, Menard J. Feasibility study of N-of-1 trials with blood pressure self-monitoring in hypertension. Hypertension 1995; 25: 294-301.
30. Knowles SR, Uetrecht JP, Shear NH. Confirming false adverse reactions to drug by performing individualized, randomized trials. Can J Clin Pharmacol 2002; 9: 149-53.
31. Menard J, Serrurier D, Bautier P, Plouin PF, Corvol P. Crossover design to test antihypertensive drugs with self-recorded blood pressure. Hypertension 1988; 11: 153-9.
32. Johannessen T. Controlled trials in single subjects. 1. Value in clinical medicine. BMJ 1991; 303: 173-4.
33. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Mitchell G. N of 1 trials. Practical tools for medication management. Aust Fam Physician 2000; 29: 1108-12.
34. Notcutt W, Price M, Miller R, Newport S, Phillips C, Simmons S, Sansom C. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies. Anaesthesia 2004; 59: 440-52.
35. Wegman AC, van der Windt DA, de Haan M, Deville WL, Fo CT, de Vries TP. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Ann RheumDis 2003; 62: 1156-61.
36. Price JD, Grimley Evans J. An N-of-1 randomized controlled trial ('N-of-1 trial') of donepezil in the treatment of non-progressive amnestic syndrome. Age Ageing 2002; 31: 307-9.
37. Jansen IH, Olde Rikkert MG, Hulsbos HA, Hoefnagels WH. Toward individualized evidence-based medicine: five "N of 1" trials of methylphenidate in geriatric patients. J Am Geriatr Soc 2001; 49: 474-6.
38. Duggan CM, Mitchell G, Nikles CJ, Glasziou PP, Del Mar CB, Clavarino A. Managing ADHD in general practice. N of 1 trials can help! Aust Fam Physician 2002; 29: 1205-9.
39. Coxeter PD, Schluter PJ, Eastwood HL, Nikles CJ, Glasziou PP. Valerian does not appear to reduce symptoms for patients with chronic insomnia in general practice using a series of randomised n-of-1 trials. Complement Ther Med 2003; 11: 215-22.
40. Hart A, Sutton CJ. N-of-1 trials and their combination: suitable approaches for CAM research? Complement Ther Med 2003; 11: 213-14.
41. Peloso PM. Are individual patient trials (n-of-1 trials) in rheumatology worth the extra effort? J Rheumatol 2004; 31: 8-11.
42. Price JD, Grimley Evans J. N-of-1 randomized controlled trials ('N-of-1 trials'): singularly useful in geriatric medicine. Age Ageing 2002; 31: 227-32.
43. Karnon J, Qizilbash N. Economic evaluation alongside n-of-1 trials: getting closer to the margin. Health Econ 2001; 10: 79-82.
44. Mahon J, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. BMJ 1996; 312: 1069-74.
45. Mahon J, Laupacis A, Hodder RV, McKim DA, Paterson NA, Wood TE et al. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest 1999; 115: 38-48.
46. Pope JE, Prashker M, Anderson J. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal anti-inflammatory drugs in osteoarthritis. J Rheumatol 2004; 31: 140-9.